LiveDNA empowers researchers, scholars, editors, reviewers, publishers, and institutions with a trusted digital identity and comprehensive professional profile.
Muhammed Ahmed-Reda Elosman

Muhammed Ahmed-Reda Elosman

Assistant Professor
Idlib University
LiveDNA ID: 90.46975
6 Publications
0 Editorial Roles
0 Projects

About

Professional Summary

My name is Muhammed Elosman, and I am a pharmacist and pharmacology researcher with an academic and professional background in pharmaceutical sciences, experimental pharmacology, and pharmaceutical quality assurance. I graduated from the Faculty of Pharmacy in 2021 with a GPA of 88.87% and subsequently completed my Master’s degree in Pharmacology at Mersin University, graduating with a GPA of 92.17%.

My academic training has provided me with a strong foundation in pharmacology, molecular biology, and experimental research. During my Master’s studies, my research focused on the role of the urotensin-II (U-II) receptor in nitric oxide-mediated hypotension in an experimental model of septic shock, with particular emphasis on evaluating the potential therapeutic effects of the U-II receptor antagonist SB-710411. This research allowed me to develop practical expertise in experimental pharmacology and molecular biology techniques, including Western blotting and co-immunoprecipitation, while strengthening my ability to design experiments, analyze scientific data, and critically evaluate research findings.

In addition to my academic experience, I have developed professional expertise in pharmaceutical and food supplement manufacturing, particularly in Quality Assurance. At BioPharma, I have been involved in the development and implementation of quality management systems, preparation and review of GMP-related documentation and SOPs, deviation investigations, environmental monitoring, and quality improvement activities. This experience has provided me with a comprehensive understanding of pharmaceutical manufacturing processes, quality systems, regulatory expectations, and the critical role of quality assurance in ensuring the safety, efficacy, and consistency of products.

My primary academic interests lie in pharmacology, drug discovery and development, molecular mechanisms of disease, and translational pharmaceutical research. I am particularly motivated to investigate novel therapeutic targets and mechanisms that can contribute to the development of safer and more effective treatments.

My long-term objective is to pursue a PhD in Pharmaceutical Sciences and establish a career in academic and pharmaceutical research. I aim to integrate my background in pharmacy, experimental pharmacology, and pharmaceutical quality with advanced research methodologies to contribute to innovative and clinically relevant scientific discoveries.

Employment

Professional Appointments
Assistant Professor
Idlib University
Jan 2026 — Present | Syria

Education

Academic Background
  • Ph.D. Mersin University, Yenisehir Kampusu, Mersin, Turkiye Pharmaceutical Sciences, Pharmacology | Jan 2025 — Present

Publications (6)

Selected Scholarly Contributions
EFFECTS OF THE UROTENSIN-II RECEPTOR ANTAGONIST SB-710411 ON REMOTE ISCHEMIC PRECONDITIONING IN A RAT MODEL OF LPS-INDUCED ENDOTOXIC SHOCK: CARDIOVASCULAR RESPONSE, INFLAMMATORY INJURY, AND SURVIVAL
Parinaz Amini Didani, Muhammed Ahmed-Reda Elosman, Sefika Pinar Senol, Elif Ikiz, Tuba Kara, Lutfiye Kara, Bahar Tunctan
Shock | Journal Article
Crossref
2026
Effects of RIPK1 inhibitor necrostatin-1s on cardiovascular responses and inflammatory damage in a bilateral hind limb I/R injury model in rats
Elif Ikiz, Muhammed Ahmed-Reda Elosman, Sefika Pinar Senol, Tuba Kara, Bahar Tunctan
Pharmacia | Journal Article
Crossref
2026
Inhibition of RIPK1-driven necroptosis ameliorates inflammatory hyperalgesiacaused by lipopolysaccharide: involvement of TLR-, NLRP3-, and caspase-11-mediated signaling pathways
Seda Kurt, Sefika Pinar Senol, Dilsah Ezgi Yilmaz, Omer Bahceli, Beyza Ozgen, Zainab Sabrie, Muhammed Ahmed-Reda Elosman, Bahar Tunctan
Cellular and Molecular Biology | Journal Article
Crossref
2025
RIPK1/RIPK3/MLKL Necrosome Contributes to the Sepsis-Induced Cardiorenal Necroptotic Inflammatory Injury and Mortality
Bahar Tunctan, Muhammed Ahmed-Reda Elosman, Sefika Pinar Senol, Elif Ikiz, Tuba Kara
Current Molecular Pharmacology | Journal Article
Crossref
2025
Urotensin-II receptor contributes to the pro-inflammatory TLR4/MyD88NF-κB/iNOS/NO pathway-mediated cardiovascular response to systemiclipopolysaccharide challenge in a septic shock model in rats
Muhammed Ahmed-Reda Elosman, Sefika Pinar Senol, Elif Ikiz, Bahar Tunctan
Cellular and Molecular Biology | Journal Article
Crossref
2025
Inhibition of the RIPK1-driven necroptotic pathway protects against hypotensiveand tachycardic responses to LPS in a rat model of septic shock
Bahar Tunctan, Sefika Pinar Senol, Dilsah Ezgi Yilmaz, Omer Bahceli, Tuba Kara, Muhammed Ahmed-Reda Elosman
Cellular and Molecular Biology | Journal Article
Crossref
2025